NASDAQ Companies

Preliminary Q4 2023 revenue expected to be between $10.4 and $10.7 million, which would represent an estimated increase of 27% […]

PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea […]

Beijing, Jan. 08, 2024 (GLOBE NEWSWIRE) — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global […]

Multiple data catalysts across all clinical programs expected throughout 2024, including data for WVE-006 in AATD which would provide first-ever […]

— Polymorph and Stereoisomer Patents when Issued Extend Portfolio to at least 2045 — — Polymorph and Stereoisomer Patent Filings Continue to […]

SAN DIEGO, Jan. 08, 2024 (GLOBE NEWSWIRE) — Ambrx Biopharma, Inc., or Ambrx (NASDAQ: AMAM), today announced that it has […]

EMERYVILLE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today the Board […]

CLEVELAND, Jan. 08, 2024 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has entered into a […]

AUSTIN, Texas, Jan. 08, 2024 (GLOBE NEWSWIRE) — Mondee Holdings, Inc. (Nasdaq: MOND) (“Mondee” or the “Company”), a leading AI […]

FREMONT, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, and Group14 […]